参考文献/References:
[1] Albanese A,Bhatia K,Bressman SB,et al.Phenomenology and classification of dystonia: A consensus update[J].Movement Disorders,2013,28(7):863-873.
[2] Fung VS,Jinnah H,Bhatia K,et al.Assessment of patients with isolated or combined dystonia:an update on dystonia syndromes[J].Mov Disord,2013,28(7):889-898.
[3] Xiao J,Uitti RJ,Zhao Y,et al.Mutations in CIZ1 cause adult onset primary cervical dystonia[J].Ann Neurol,2012,71(3):458-469.
[4] Fuchs T,Saunders-Pullman R,Masuho I,et al.Mutations in GNAL cause primary torsion dystonia[J].Nat Genet,2013,45(1):88-U128.
[5] Charlesworth G,Plagnol V,Holmstroem KM,et al.Mutations in ANO3 cause dominant craniocervical dystonia: ion Channel implicated in pathogenesis[J].Am J Hum Genet,2012,91(6):1041-1050.
[6] Ma L,Chen R,Wang L,et al.No mutations in CIZ1 in twelve adult-onset primary cervical dystonia families[J].Mov Disord,2013,28(2):1899-1901.
[7] Stamelou M,Charlesworth G,Cordivari C,et al.The phenotypic spectrum of DYT24 due to ANO3 mutations[J].Mov Disord,2014,29(7):928-934.
[8] Zech M,Gross N,Jochim A,et al.Rare sequence variants in ANO(3)and GNAL in a primary torsion dystonia series and controls[J].Movement Disorders,2014,29(1):143-147.
[9] Vemula SR,Puschmann A,Xiao J,et al.Role of Ga(olf)in familial and sporadic adult-onset primary dystonia[J].Hum Mol Genet,2013,22(1):2510-2519.
[10] Dufke C,Sturm M,Schroeder C,et al.Screening of mutations in GNAL in sporadic dystonia patients[J].Movement Disorders,2014,29(9):1193-1196.
[11] Kumar KR,Lohmann K,Masuho I,et al.Mutations in GNAL:a novel cause of craniocervical dystonia[J].JAMA Neurol,2014,71(4):490-494.
[12] Dobricic V,Kresojevic N,Westenberger AA,et al.De Novo mutation in the GNAL gene causing seemingly sporadic dystonia in a serbian patient[J].Movement Disorders,2014,29(9):1190-1193.
[13] Miao J,Wan XH,Sun Y,et al.Mutation screening of GNAL gene in patients with primary dystonia from Northeast China[J].Parkinsonism Relat Disord,2013,19(10):910-912.
[14] Saunders-Pullman R,Fuchs T,San Luciano MA,et al.Heterogeneity in primary dystonia: lessons from THAP1, GNAL, and TOR1A in Amish-Mennonites[J].Movement Disorders,2014,29(6):812-818.
[15] Charlesworth G,Bhatia KP,Wood NW.No pathogenic GNAL mutations in 192 sporadic and familial cases of cervical dystonia[J].Movement Disorders,2014,29(1):154-155.
[16] Belluscio L,Gold GH,Nemes A,et al.Mice deficient in G(olf)are anosmic[J].Neuron,1998,20(1):69-81.
[17] Wilcox RA,Winkler S,Lohmann K,et al.Whispering dysphonia in an Australian family(DYT4): A clinical and genetic reappraisal[J].Movement Disorders,2011,26(13):2404-2408.
[18] Hersheson J,Mencacci NE,Davis M,et al.Mutations in the autoregulatory domain of b-tubulin 4a cause hereditary dystonia[J].Ann Neurol,2013,73(4):546-553.
[19] Lohmann K,Wilcox RA,Winkler S,et al.Whispering dysphonia(DYT4 dystonia)is caused by a mutation in the TUBB4 gene[J].Ann Neurol,2013,73(4):537-545.
[20] Vemula SR,Xiao J,Bastian RW.Mom_cilovi_c D,Blitzer A,Ledoux MS.Pathogenic variants in TUBB4A are not found in primary dystonia[J].Neurology,2014,82(5):1227-1230.
[21] Simons C,Wolf NI,Mcneil N,et al.A de novo mutation in the b-tubulin gene TUBB4A results in the leukoencephalopathy hypomyelination with atrophy of the basal ganglia and cerebellum[J].Am J Hum Genet,2013,92(5):767-773.
[22] Blumkin L,Halevy A,Ben-Ami-Raichman DA,et al.Expansion of the spectrum of TUBB4A-related disorders: a new phenotype associated with a novel mutation in the TUBB4A gene[J].Neurogenetics,2014,15(2):107-113.
[23] Hamilton EM,Polder E,Vanderver A,et al.Hypomyelination with atrophy of the basal ganglia and cerebellum: further delineation of the phenotype and genotype-phenotype correlation[J].Brain,2014,137(7):1921-1930.
[24] Ferreira C,Poretti A,Cohen J,et al.Novel TUBB4A mutations and expansion of the neuroimaging phenotype of hypomyelination with atrophy of the basal ganglia and cerebellum(H-ABC)[J].Am J Med Genet A,2014,164(7):1802-1807.
[25] Carvalho D,Santos S,Martins B,et al.TUBB4A novel mutation reinforces the genotype-phenotype correlation of hypomyelination with atrophy of the basal ganglia and cerebellum[J].Brain,2015,138(2):e327.
[26] Shimojima K,Okumura A,Ikeno M,et al.A de novo TUBB4A mutation in a patient with hypomyelination mimicking Pelizaeus_Merzbacher disease[J].Brain Dev,2015,37(2):281-285.
[27] Purnell SM,Bleyl SB,Bonkowsky JL.Clinical exome sequencing identifies a novel TUBB4A mutation in a child with static hypomyelinating leukodystrophy[J].Pediatr Neurol,2014,50(6):608-611.
[28] Pizzino A,Pierson TM,Guo Y,et al.TUBB4A de novo mutations cause isolated hypomyelination[J].Neurology,2014,83(6):898-902.
[29] Miyatake S,Osaka H,Shiina M,et al.Expanding the phenotypic spectrum of TUBB4A-associated hypomyelinating leukoencephalopathies[J].Neurology,2014,82(24):2230-2237.
[30] Erro R,Hersheson J,Ganos C,et al.H-ABC syndrome and DYT4: Variable expressivity or pleiotropy of TUBB4 mutations?[J].Movement Disorders,2015,30(6):828-833.
[31] Zimprich A,Grabowski M,Asmus F,et al.Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome[J].Nat Genet,2001,29(1):66-69.
[32] Carecchio M,Magliozzi M,Copetti M,et al.Defining the epsilon-sarcoglycan(SGCE)gene phenotypic signature in myoclonus-dystonia:a reappraisal of genetic testing criteria[J].Mov Disord,2013,28(6):787-794.
[33] Peall KJ,Kurian MA,Wardle M,et al.SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotype[J].J Neurol,2014,261(12):2296-2304.
[34] Grimes DA,Han F,Lang AE,et al.A novel locus for inherited myoclonus-dystonia on 18p11[J].Neurology,2002,59(8):1183-1186.
[35] Groen J,Van RA,Van Der Salm SM,et al.A new familial syndrome with dystonia and lower limb action myoclonus[J].Mov Disord,2011,26(6):896-900.
[36] Groen JL,Andrade A,Ritz K,et al.CACNA1B mutation is linked to unique myoclonus-dystonia syndrome[J].Hum Mol Genet,2015,24(4):987-993.
[37] Breedveld GJ,Van Dongen J,Van Der Linde H,et al.Mutations in TITF-1 are associated with benign hereditary chorea[J].Movement Disorders,2002,17(5):S321.
[38] Armstrong MJ,Shah BB,Chen R,et al.Expanding the phenomenology of benign hereditary chorea: evolution from chorea to myoclonus and dystonia[J].Movement Disorders,2011,26(12):2296-2297.
[39] Gras D,Jonard L,Roze E,et al.Benign hereditary chorea:phenotype,prognosis,therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 gene[J].J Neurol Neurosurg Psychiatry,2012,83(12):956-962.
[40] Leuzzi V,Carducci C,Carducci C,et al.Autosomal dominant GTP-CH deficiency presenting as a dopa-responsive myoclonus-dystonia syndrome[J].Neurology,2002,59(8):1241-1243.
[41] Stamelou M,Mencacci NE,Cordivari C,et al.Myoclonus-dystonia syndrome due to tyrosine hydroxylase deficiency[J].Neurology,2012,79(5):435-441.
[42] Westenberger A,Rosales RL,Heinitz SA,et al.X-linked Dystonia-Parkinsonism manifesting in a female patient due to atypical turner syndrome[J].Movement Disorders,2013,28(5):675-678.
[43] Domingo A,Lee LV,Brueggemann NA,et al.Woman with X-Linked recessive Dystonia-Parkinsonism Clue to the epidemiology of parkinsonism in filipino women?[J].JAMA Neurol,2014,71(9):1177-1180.
[44] Camargos S,Scholz S,Simon-Sanchez JA,et al.DYT16, a novel young-onset dystonia-parkinson ism disorder: identification of a segregating mutation in the stress-response protein PRKRA[J].Lancet Neurol,2008,7(3):207-215.
[45] Camargos S,Lees AJ,Singleton A,et al.DYT16: the original cases[J].J Neurol Neurosurg Psychiatry,2012,83(10):1012-1014.
[46] Zech M,Castrop F,Schormair B,et al.DYT16 revisited:exome sequencing identifies PRKRA mutations in a European dystonia family[J].Mov Disord,2014,29(12):1504-1510.
[47] Stamelou M,Lai SC,Aggarwal A,et al.Dystonic opisthotonus: a ``red flag{''} for neurodegeneration with brain Iron accumulation syndromes?[J].Movement Disorders,2013,28(10):1325-1329.
[48] Lemmon ME,Lavenstein B,Applegate CD,et al.A novel presentation of DYT 16: acute onset in infancy and association with MRI abnormalities[J].Movement Disorders,2013,28(14):1937-1938.
[49] Aguiar PD,Sweadner KJ,Penniston JT,et al.Mutations in the Na+/K+-ATPase alpha 3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism[J].Neuron,2004,43(2):169-175.
[50] Heinzen EL,Swoboda KJ,Hitomi Y,et al.De novo mutations in ATP1A3 cause alternating hemiplegia of childhood[J].Nat Genet,2012,44(9):1030.
[51] Rosewich H,Thiele H,Ohlenbusch AA,et al.Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study[J].Lancet Neurol,2012,11(9):764-773.
[52] Brashear A,Mulholland GK,Zheng QH,et al.PET imaging of the presynaptic dopamine uptake sites in rapid-onset dystoniaparkinsonism(RDP)[J].Mov Disord,1999,14(1):132-137.
[53] Zanotti-Fregonara P,Vidailhet M,Kas A,et al.-FP-CIT and[99mTc]-HMPAO single photon emission computed tomography in a new sporadic case of rapidonset dystonia-parkinsonism[J].J Neurol Sci,2008,273(1/2):148-151.
[54] Rosewich H,Ohlenbusch A,Huppke PA,et al.The expanding clinical and genetic spectrum of ATP1A3-related disorders[J].Neurology,2014,82(11):945-955.
[55] Fornarino S,Stagnaro M,Rinelli M,et al.Paroxysmal features responding to flunarizine in a child with rapidonset dystonia-parkinsonism[J].Neurology,2014,82(22):2037-2038.
[56] Brashear A,Mink JW,Hill DF,et al.ATP1A3 mutations in infants: a new rapid-onset dystonia-Parkinsonism phenotype characterized by motor delay and ataxia[J].Dev Med Child Neurol,2012,54(11):1065-1067.
[57] Roubergue A,Roze E,Vuillaumier-Barrot S,et al.The multiple faces of the ATP1A3-related dystonic movement disorder[J].Mov Disord,2013,28(10):1457-1459.
[58] Cook JF,Hill DF,Snively BM,et al.Cognitive impairment in Rapid-Onset Dystonia-Parkinsonism[J].Movement Disorders,2014,29(3):344-350.
[59] Brashear A,Cook JF,Hill DF,et al.Psychiatric disorders in rapid-onset dystonia-parkinsonism[J].Neurology,2012,79(11):1168-1173.
[60] Barbano RL,Hill DF,Snively BM,et al.New triggers and non-motor findings in a family with rapid-onset dystonia-parkinsonism[J].Parkinsonism Relat Disord,2012,18(6):737-741.
[61] Demos MK,Van Karnebeek CD,Ross CJ,et al.A novel recurrent mutation in ATP1A3 causes CAPOS syndrome[J].Orphanet J Rare Dis,2014,9(15):1-9.
[62] Rosewich H,Weise D,Ohlenbusch AA,et al.PHENOTYPIC OVERLAP OF ALTERNATING HEMIPLEGIA OF CHILDHOOD AND CAPOS SYNDROME[J].Neurology,2014,83(9):861-863.
[63] Sasaki M,Ishii A,Saito Y,et al.Genotype-phenotype correlations in alternating hemiplegia of childhood[J].Neurology,2014,82(6):482-490.
[64] Ulate-Campos A,Fons C,Artuch R,et al.Alternating hemiplegia of childhood with a de Novo mutation in ATP1A3 and changes in SLC2A1 responsive to a ketogenic Diet[J].Pediatr Neurol,2014,50(4):377-379.
[65] Roubergue A,Philibert B,Gautier A,et al.Excellent response to a ketogenic diet in a patient with alternating hemiplegia of childhood[J].JIMD Rep,2015,15(1):7-12.
[66] Novy J,Mcwilliams E,Sisodiya SM.Asystole in alternating hemiplegia with de novo ATP1A3 mutation[J].Eur J Med Genet,2014,57(1):37-39.
[67] Bottger P,Tracz Z,Heuck A,et al.Distribution of Na/K-ATPase alpha 3 isoform, a Sodium-Potassium P-Type pump associated with Rapid-Onset of dystonia parkinsonism(RDP)in the adult mouse brain[J].Journal of Comparative Neurology,2011,519(2):376-404.
[68] Calderon DP,Fremont R,Kraenzlin FA.The neural substrates of rapid-onset Dystonia-Parkinsonism[J].Nat Neurosci,2011,14(3):357-365.
[69] Fremont R,Calderon DP,Maleki S,et al.Abnormal High-Frequency burst firing of cerebellar neurons in Rapid-Onset Dystonia-Parkinsonism[J].Journal of Neuroscience,2014,34(35):11723-11732.
[70] Kurian MA,Zhen J,Cheng SY,et al.Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia[J].Journal of Clinical Investigation,2009,119(6):1595-1603.
[71] Ng J,Zhen J,Meyer E,et al.Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood[J].Brain,2014,137(4):1107-1119.